The pharmaceutical industry has seen unprecedented disruptions. The fallout has included demand, supply and logistics shocks such as hoarding-induced artificial shortfalls, supply constraints on active ingredients and expedients, transportation disruptions, and port closures. In addition, global pharmaceutical supply chains are becoming increasingly complex as companies address pricing and regulatory pressures, shorter product lifecycles and time-to-market competition.
Challenges that Accompany the Benefits
To compete, pharmaceutical companies are reassessing their core competencies and identifying partners for outsourcing—such as contract manufacturers—at an increasing rate. With all the benefits of outsourcing comes the loss of visibility and control. When you add in major disruptions, it becomes clear that a connected supply chain ecosystem is essential. E2open helps address these concerns with technologies and applications supported by a connected business network, enabling you to efficiently access and analyze data and collaborate across your network to handle issues together with your partners.
Disruptions aren’t rare—they are expected. With E2open, you can anticipate them, prepare ahead of time and take action based on current, decision-grade data.